← Leaderboards
Joseph H Neale
Georgetown University
$5,509,866
Attributed
$5,509,866
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $802.3K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$5,509,866 · 3
By mechanism
R01$5,509,866 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Glutamates”
- Merit E Cudkowicz · Massachusetts General Hospital$40,827,833
- Alan G. Barbour · University Of California Irvine$39,660,285
- Scott W Woods · Yale University$33,212,495
- Paul F Worley · Johns Hopkins University$32,678,609
- Richard L Huganir · Johns Hopkins University$30,324,803
- John M Kane · Long Island Jewish Medical Center$28,729,148
Research focus
GlutamatesLaboratory MouseSynapsesTissue /Cell CultureGlutamate ReceptorLaboratory RatCarboxypeptidaseDipeptidesNeuropeptidesPathway InteractionsLaboratoriesMediatingNeurotransmittersPeptide HydrolasesAgonistAnalogNeuronsIn VivoExtracellularChronicMicrodialysisGlutamate Carboxypeptidase IiAnimal ModelAcute
Grant awards (18)
Neurochemical and Behavioral Activity of NAAG in Animal Models of Schizophrenia$335,371
R01 · FY2011 · MH · contact PI
Neurochemical and Behavioral Activity of NAAG in Animal Models of Schizophrenia$338,759
R01 · FY2010 · MH · contact PI
Neurochemical and Behavioral Activity of NAAG in Animal Models of Schizophrenia$338,759
R01 · FY2009 · MH · contact PI
Neurochemical and Behavioral Activity of NAAG in Animal Models of Schizophrenia$352,134
R01 · FY2008 · MH · contact PI
NAAG Peptidase and Neuronal Function$340,303
R01 · FY2008 · NS · contact PI
NAAG Peptidase and Neuronal Function$36,700
R01 · FY2008 · NS · contact PI
NAAG Peptidase and Neuronal Function$340,303
R01 · FY2007 · NS · contact PI
NAAG Peptidase and Neuronal Function$345,979
R01 · FY2006 · NS · contact PI
Developing NAAG Peptidase Inhibitors for Neuroprotection$443,386
R01 · FY2005 · NS
NAAG Peptidase and Neuronal Function$358,900
R01 · FY2005 · NS
Developing NAAG Peptidase Inhibitors for Neuroprotection$430,925
R01 · FY2004 · NS
Developing NAAG Peptidase Inhibitors for Neuroprotection$481,838
R01 · FY2003 · NS
NAAG PEPTIDASE AND NEURONAL FUNCTION$240,596
R01 · FY2003 · NS
Developing NAAG Peptidase Inhibitors for Neuroprotection$397,684
R01 · FY2002 · NS
NAAG PEPTIDASE AND NEURONAL FUNCTION$245,702
R01 · FY2002 · NS
NAAG PEPTIDASE AND NEURONAL FUNCTION$245,128
R01 · FY2001 · NS
NAAG PEPTIDASE AND NEURONAL FUNCTION$3,399
R01 · FY2001 · NS
NAAG PEPTIDASE AND NEURONAL FUNCTION$234,000
R01 · FY2000 · NS